CVCamila Silva Vidal

Camila Silva Vidal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Camila Silva Vidal has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Punica granatum as a source of novel antibacterial agents for combating bovine mastitis and multidrug resistance

    by Alexander M. Cardoso, Tauana Freitas, Camila S. Vidal, Jamila A. Perini, Ida C. N. Direito, Cristiane P. Victório, João B. de Salles, Maria C. de Assis

    Antimicrobial resistance has emerged as a major challenge for both human and veterinary health, highlighting the need for novel therapeutic approaches. Bovine mastitis remains one of the most economically significant infectious diseases affecting dairy production worldwide. In this narrative review, we examine current evidence regarding the antibacterial potential of Punica granatum L. (pomegranate) and its major bioactive constituents, particularly punicalagin, against clinically relevant multidrug-resistant bacterial pathogens. Recent studies indicate that pomegranate-derived extracts possess antibacterial activity against several mastitis-associated organisms, including Staphylococcus aureus and Escherichia coli. Experimental evidence suggests that punicalagin may contribute to membrane destabilization, increased membrane permeability, interference with biofilm formation, and modulation of bacterial stress-response pathways, although the relative importance of these mechanisms appears to vary among bacterial species and experimental systems. Several studies have also reported synergistic interactions between pomegranate-derived compounds and conventional antibiotics against selected multidrug-resistant pathogens. Despite these promising findings, the current evidence remains dominated by in vitro investigations, while in vivo efficacy, pharmacokinetic characterization, toxicological assessment, and clinical validation remain limited.

  • Open Access

    Rapid Bactericidal Activity of Punica granatum L. Peel Extract: A Natural Alternative for Mastitis Prevention in Dairy Cattle

    by Carenn Rodrigues e Almeida Silva, Camila Silva Vidal, Sergio Martins de Andrade Filho, Izabela Martins Agatão, Lidiane Coelho Berbert, João Bosco de Salles, Alexander Machado Cardoso, Ricardo Machado Kuster, Cristiane Pimentel Victório, Maria Cristina de Assis

    The increasing prevalence of bacterial resistance to conventional disinfectants and antibiotics has intensified the search for effective, natural alternatives in the dairy industry. This study evaluates the bactericidal efficacy of Punica granatum L. (pomegranate) peel ethanolic extract, focusing on its application in pre- and post-dipping procedures for mastitis prevention. The extract exhibited potent activity against Escherichia coli and Staphylococcus aureus, two major mastitis pathogens. At a concentration of 10 mg/mL, the extract induced significant membrane disruption within 30 s of exposure, as evidenced by propidium iodide uptake and elevated extracellular DNA levels (Escherichia coli: 64.25 ng/μL; Staphylococcus aureus: 83.25 ng/μL) compared to controls (11.20 ng/μL and 35.20 ng/μL, respectively; p < 0.05). Complete growth inhibition (100%) was achieved within 30 s at 25 and 50 mg/mL, matching the efficacy of commercial chlorhexidine and high-concentration hypochlorite. Phytochemical analysis identified punicalagin as the predominant bioactive compound. These findings establish Punica granatum peel extract as a fast-acting bactericidal agent, exhibiting an efficacy comparable to or exceeding that of conventional disinfectants. Its rapid action and plant-based origin highlight its potential as a viable alternative for the prevention and control of bovine mastitis in dairy farming.


  • Technological mapping of plant-based patents for treating bovine mastitis

    by Camila Silva Vidal, Gustavo Henrique Santos de Carvalho, Maria Cristina de Assis, Renata Angeli, Cristiane Pimentel Victório

    Bovine mastitis costs the world’s economy an estimated USD 19.7–32 billion annually. Plant-based products have been used as alternative treatme


  • Open Access

    Medicamentos fitoterápicos e aplicação veterinária em âmbito nacional

    by Camila Silva Vidal, Renata Angeli, Cristiane Pimentel Victório

    As plantas medicinais e seus derivados dispõe de inúmeras propriedades terapêuticas, são empregadas na prevenção e tratamento de enfermidades de humanos e animais. O mercado de saúde veterinária vem ganhando notoriedade devido ao crescente número de doenças entre os animais, a elevada demanda por animais de companhia e a observância da segurança alimentar. A busca de tratamentos à base de plantas é consequência das adversidades dos tratamentos convencionais como antibióticos. No entanto, o uso de plantas na medicina veterinária é modesto, mesmo o Brasil sendo o segundo país com a maior população de animais de estimação do mundo e sua considerável participação na produção de animais. Entre os fitomedicamentos e fitoterápicos é relevante a aplicação de produtos dermatológicos, de infecções parasitárias, distúrbios gastrointestinais e do sistema nervoso. Os antiparasitários são os mais abundantes entre os produtos registrados. A empresa Winner Horse, Multiboi Nutrição Animal e Provets Simões Lab. tem o maior número de registros de fitomedicamentos de uso veterinário. É necessário um maior investimento em fitomedicamentos para uso veterinário, visto o significativo potencial terapêutico, e se apresentam como uma solução para alguns problemas resultantes do uso indiscriminado e contínuo de fármacos convencionais.


  • Open Access

    Patents of plant products applied to bovine mastitis in the INPI

    by Vidal, Gustavo Henrique Santos de Carvalho, Maria Cristina de Assis, Renata Angeli, Cristiane Pimentel Victorio, Camila Silva Vidal

    Bovine mastitis is an inflammation of the mammary gland of dairy cattle, and it significantly affects the dairy sector. Its frequent treatment is the use of antibiotics, but they cause several problems, such as the formation of resistant pathogens. Hence, one treatment option is the use of medicinal plant-based products. Brazil is among the largest cattle breeders. It has a rich floristic diversity, and there is widespread knowledge about the therapeutic properties of plants. This study provides a patent map that is derived from Brazil's INPI online database (Brazilian Patent Office). There were 109 patent applications related to mastitis, being 17 patent applications with medicinal plants to treat this disease. Brazil was the largest depositor of patent applications with 37 requests, followed by the United States with 22 applications. The most frequent International Patent Classification was A61K31. Companies are the main applicants, but Science and Technology Institutions showed a significant participation among patent applications that contained medicinal plants in their composition. A patent map is a useful tool for identifying possible technological opportunities.